EP3114139
Mótefni gegn eótaxín-2 sem þekkja fleiri CCR3-bindandi flakkboða
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
4.3.2015EP published:
15.6.2022EP application number:
15714963.4
EP translation filed:
26.8.2022Grant published:
15.9.2022EPO information:
European Patent Register
Max expiry date:
3.3.2035Expiry date:
3.3.2027Next due date:
31.3.2027
Title in English:
ANTI EOTAXIN-2 ANTIBODIES THAT RECOGNIZE ADDITIONAL CCR3-BINDING CHEMOKINESLanguage of the patent:
English
Timeline
Today
4.3.2015EP application
15.6.2022EP Publication
26.8.2022Translation submitted
15.9.2022Registration published
3.3.2027Expires
Owner
Name:
Chemomab Ltd.Address:
Kiryat Aditim, Building 7, Entrance B, 6158002 Tel Aviv, IL
Inventor
Name:
MOR, AdiAddress:
6901872 Tel Aviv, IL
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201461947852 PDate:
4.3.2014Country:
US
Classification
Categories:
C07K 16/24, C12N 15/13, A61K 39/395, A61P 37/00
Annual fees
Number
Paid
Expires
Payer
Number: 9
Paid: 26.2.2023
Expires: 3.3.2024
Payer: Árnason Faktor ehf.
Number: 10
Paid: 23.2.2024
Expires: 3.3.2025
Payer: Árnason Faktor ehf.
Number: 11
Paid: 13.2.2025
Expires: 3.3.2026
Payer: Árnason Faktor ehf.
Number: 12
Paid: 20.3.2026
Expires: 3.3.2027
Payer: Árnason Faktor ehf.